BCG Report Finds 350 Billion Dollar Gap in Women's Health Needs, Especially During Menopause
A Boston Consulting Group analysis identified a $350 billion "longevity mismatch" in women's health, finding that women face the highest rates of unmet health needs, particularly during perimenopause and menopause. The report says health systems have not built adequate products or services for women as they age. The Global Wellness Institute highlighted the findings in its September 2026 roundup.
A Boston Consulting Group analysis released in September 2026 identified a $350 billion gap in women's health, describing it as a "longevity mismatch" driven by the failure of health systems to meet women's needs as they age.
The report found that women, particularly during perimenopause and menopause, face the highest rates of unmet health needs of any demographic group. Despite living longer than men on average, women spend more years in poor health, and the products and services designed to address their specific needs have not kept pace.
Perimenopause and menopause affect roughly half the global population at some point, yet research funding and clinical attention have historically been concentrated on conditions that affect men or younger populations.
The BCG analysis put a dollar figure on the gap, estimating that $350 billion in economic value is lost annually because women's health needs go unaddressed. That figure accounts for lost productivity, higher healthcare costs from untreated conditions, and reduced quality of life.
The Global Wellness Institute featured the report in its September 2026 must-reads, noting that the findings align with a broader industry push toward women-specific health solutions.
Several companies have moved into the space in recent years, offering products targeting hormonal health, bone density, and cardiovascular risk in midlife women. But the BCG report suggests the market remains far from meeting the actual scale of need.
Researchers and advocates say the findings should prompt both greater investment in women's health research and changes in how health systems screen and treat women in their 40s and 50s.